CERVOMED INC (CRVO) Stock Earnings & Estimates
NASDAQ:CRVO - US15713L1098 - Common Stock
10 USD
-0.28 (-2.72%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.145M | 9.738M 36.29% | 6.926M -28.88% | -100.00% | 1.02M | 82.21M 7,959.80% | 163.07M 98.36% | 1.463B 797.16% | 2.806B 91.80% | |||
| EBITDA YoY % growth | -15.97M -0.13% | N/A 8.03% | N/A -18.75% | -26.622M -52.63% | -66.198M -148.66% | -69.156M -4.47% | -70.38M -1.77% | -49.98M 28.99% | -220.32M -340.82% | 130.05M 159.03% | 414.63M 218.82% | |
| EBIT YoY % growth | -15.97M 0.44% | -7.013M 56.09% | -18.227M -159.91% | -25.973M -42.50% | -52.637M -102.66% | -59.126M -12.33% | -62.39M -5.52% | 23.249M 137.26% | -20.705M -189.06% | 1.128B 5,547.83% | 2.303B 104.17% | |
| Operating Margin | N/A | -98.15% | -187.17% | -375.01% | N/A | N/A | -6,116.67% | 28.28% | -12.70% | 77.10% | 82.07% | |
| EPS YoY % growth | N/A 14.86% | N/A 82.98% | -2.03 -47.42% | -2.27 -11.85% | -2.14 5.93% | -1.96 8.31% | -1.53 21.87% | -0.43 72.00% | -2.11 -392.86% | 7.31 446.38% | 13.86 89.54% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.81 -47.44% | -0.48 39.76% | -0.62 -11.11% | -0.64 8.20% | -0.72 10.69% | -0.77 -58.73% |
| Revenue Q2Q % growth | 1.632M -15.88% | 1.55M -28.31% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -7.854M -97.44% | -8.874M -42.62% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.686M -23.91% | -7.139M 1.40% | -9.903M -86.75% | -10.388M -57.00% | -10.914M -63.23% | -13.158M -84.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.70 -159.26% | -0.64 | -0.06 | -8.93% |
| Q1 2025 Q2Q % growth | -0.56 -36.59% | -0.67 | 0.11 | 16.71% |
| Q4 2024 Q2Q % growth | -0.80 -110.53% | -0.64 | -0.16 | -24.49% |
| Q3 2024 Q2Q % growth | -0.55 21.43% | -0.42 | -0.13 | -30.72% |
| Q2 2024 Q2Q % growth | -0.27 86.28% | -0.31 | 0.04 | 13.49% |
| Q1 2024 Q2Q % growth | -0.41 78.95% | -0.40 | -0.01 | -3.07% |
| Q4 2023 Q2Q % growth | -0.38 83.07% | -0.30 | -0.08 | -28.47% |
| Q3 2023 Q2Q % growth | -0.70 65.94% | -0.97 | 0.27 | 27.76% |
| Q2 2023 Q2Q % growth | 36.29% | -1.97 | % | |
| Q1 2023 Q2Q % growth | 41.50% | -1.95 | % | |
| Q4 2022 Q2Q % growth | 25.20% | -2.24 | % | |
| Q3 2022 Q2Q % growth | -2.06 -37.00% | -3.15 | 1.10 | 34.80% |
| Q2 2022 Q2Q % growth | -3.09 -54.50% | -3.12 | 0.03 | 1.00% |
| Q1 2022 Q2Q % growth | -3.33 -11.00% | -2.68 | -0.65 | -24.37% |
| Q4 2021 Q2Q % growth | -3.00 | -3.06 | 0.06 | 1.96% |
| Q3 2021 Q2Q % growth | -1.50 57.14% | -2.04 | 0.54 | 26.47% |
| Q2 2021 Q2Q % growth | -2.00 33.33% | -2.30 | 0.29 | 12.85% |
| Q1 2021 Q2Q % growth | -3.00 14.29% | -2.30 | -0.71 | -30.72% |
| Q4 2020 Q2Q % growth | -3.00 45.45% | -2.55 | -0.45 | -17.65% |
| Q3 2020 Q2Q % growth | -3.50 88.33% | -2.81 | -0.69 | -24.78% |
| Q2 2020 Q2Q % growth | -3.00 90.48% | -2.81 | -0.19 | -6.95% |
| Q1 2020 Q2Q % growth | -3.50 91.36% | -4.34 | 0.84 | 19.26% |
| Q4 2019 Q2Q % growth | -5.50 | -6.89 | 1.38 | 20.12% |
| Q3 2019 Q2Q % growth | -30.00 | -36.21 | 6.21 | 17.15% |
| Q2 2019 Q2Q % growth | -31.50 | -35.19 | 3.69 | 10.49% |
| Q1 2019 Q2Q % growth | -40.50 | -46.16 | 5.66 | 12.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.758M -46.56% | 1.768M | -10.28K | -0.58% |
| Q1 2025 Q2Q % growth | 1.917M -18.32% | 1.756M | 161K | 9.17% |
| Q4 2024 Q2Q % growth | 2.162M -13.19% | 1.782M | 380K | 21.32% |
| Q3 2024 Q2Q % growth | 1.94M 27.13% | 3.128M | -1.188M | -37.98% |
| Q2 2024 Q2Q % growth | 3.289M 5.08% | 2.244M | 1.045M | 46.57% |
| Q1 2024 Q2Q % growth | 2.347M | 1.377M | 970K | 70.44% |
| Q4 2023 Q2Q % growth | 2.491M | 2.04M | 450.58K | 22.09% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -54.07% | -112% | -9.98% | -9.33% |
| Revenue | 17.66% | 52.38% | 7.83% | 22.19% |